Total Payments
$10,932
2024 Payments
$1,079
Companies
60
Transactions
789
Medicare Patients
1,502
Medicare Billing
$150,710
Payment Breakdown by Category
Food & Beverage$10,911 (99.8%)
Education$20.76 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,911 | 787 | 99.8% |
| Education | $20.76 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,567 | 128 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,200 | 87 | $0 (2024) |
| Lilly USA, LLC | $977.07 | 86 | $0 (2024) |
| ABBVIE INC. | $944.58 | 96 | $0 (2024) |
| GlaxoSmithKline, LLC. | $577.23 | 44 | $0 (2024) |
| PFIZER INC. | $576.72 | 41 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $573.05 | 21 | $0 (2024) |
| Abbott Laboratories | $461.26 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $402.60 | 39 | $0 (2022) |
| Amgen Inc. | $334.81 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,079 | 69 | AstraZeneca Pharmaceuticals LP ($153.35) |
| 2023 | $1,517 | 109 | Boehringer Ingelheim Pharmaceuticals, Inc. ($213.05) |
| 2022 | $1,975 | 127 | Abbott Laboratories ($261.60) |
| 2021 | $2,346 | 169 | AbbVie Inc. ($307.88) |
| 2020 | $990.92 | 71 | Novo Nordisk Inc ($293.59) |
| 2019 | $1,377 | 127 | Novo Nordisk Inc ($290.47) |
| 2018 | $1,541 | 109 | Novo Nordisk Inc ($338.34) |
| 2017 | $106.29 | 8 | PFIZER INC. ($14.74) |
All Payment Transactions
789 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Obesity | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Insomnia | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Insomnia | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 352 | 492 | $93,931 | $41,102 |
| 2022 | 10 | 407 | 635 | $108,159 | $49,340 |
| 2021 | 9 | 414 | 604 | $74,056 | $36,421 |
| 2020 | 8 | 329 | 478 | $53,368 | $23,847 |
Total Patients
1,502
Total Services
2,209
Medicare Billing
$150,710
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 298 | $54,832 | $24,176 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $25,502 | $10,062 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 35 | $4,515 | $2,127 | 47.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,460 | $2,063 | 37.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 25 | $2,351 | $1,785 | 75.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 31 | $1,271 | $889.08 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 348 | $64,007 | $29,422 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 83 | $10,685 | $4,658 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $10,457 | $4,603 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $9,084 | $3,628 | 39.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $8,418 | $3,510 | 41.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 29 | 30 | $2,664 | $2,046 | 76.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 32 | $1,312 | $870.68 | 66.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 14 | $1,106 | $515.43 | 46.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 16 | $192.00 | $47.49 | 24.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 18 | $234.00 | $40.10 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 123 | 247 | $43,371 | $20,605 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 86 | $10,448 | $5,271 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $5,150 | $3,181 | 61.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $6,712 | $2,772 | 41.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 34 | 35 | $3,045 | $2,276 | 74.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 33 | $2,442 | $1,417 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 36 | $1,476 | $566.38 | 38.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 69 | 96 | $1,152 | $288.00 | 25.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 20 | $260.00 | $45.00 | 17.3% |
About Dr. Scott Melson, MD
Dr. Scott Melson, MD is a Pediatrics healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1518252360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Melson, MD has received a total of $10,932 in payments from pharmaceutical and medical device companies, with $1,079 received in 2024. These payments were reported across 789 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($10,911).
As a Medicare-enrolled provider, Melson has provided services to 1,502 Medicare beneficiaries, totaling 2,209 services with total Medicare billing of $150,710. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Location Oklahoma City, OK
- Active Since 06/09/2011
- Last Updated 06/09/2011
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1518252360
Products in Payments
- JARDIANCE (Drug) $1,095
- Ozempic (Drug) $662.36
- TRULICITY (Drug) $394.56
- FARXIGA (Drug) $373.06
- Saxenda (Drug) $348.96
- JANUVIA (Drug) $308.12
- XIFAXAN (Drug) $300.83
- EUCRISA (Drug) $291.73
- NURTEC ODT (Drug) $257.49
- UBRELVY (Drug) $252.79
- TRELEGY ELLIPTA (Drug) $229.99
- FREESTYLE LIBRE 2 (Device) $198.35
- EVENITY (Biological) $195.43
- VRAYLAR (Drug) $188.98
- EMGALITY (Drug) $186.76
- Rybelsus (Drug) $180.25
- Azstarys (Drug) $176.03
- MOUNJARO (Drug) $173.96
- QULIPTA (Drug) $167.58
- FREESTYLE LIBRE 3 (Device) $165.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Oklahoma City
Dr. Maryam Shambayati, D.o, D.O
Pediatrics — Payments: $187,302
Pediatrics $187,302
Osman Khan, M.d, M.D
Pediatrics — Payments: $134,738
Pediatrics $134,738
Joe Ghata, Md, MD
Pediatrics — Payments: $24,965
Pediatrics $24,965
Stuart Schrader, D.o, D.O
Pediatrics — Payments: $14,020
Pediatrics $14,020
Patrick Garrison, Md, MD
Pediatrics — Payments: $13,538
Pediatrics $13,538
Alisha Solomon, Md, MD
Pediatrics — Payments: $9,605
Pediatrics $9,605